News
![AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders: https://mms.businesswire.com/media/20191108005662/en/711989/5/AGEX_High_Resolution_300dpi.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2s1RUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--00ef9f30c62ad613a4ffc2725532c06aa86f7fef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AGEX_High_Resolution_300dpi.jpg?locale=us)
AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today a research collaboration with the
![Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
![AGCO Invests in Apex.AI, a Developer of Safety-Certified Software for Mobility and Autonomous Applications: https://mms.businesswire.com/media/20191202006003/en/760023/5/agco_logo_w_descriptor2C.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNWtQRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--cbb1421fec95e3ece5874ed909c52ae991079b7a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/agco_logo_w_descriptor2C.jpg?locale=us)
AGCO Invests in Apex.AI, a Developer of Safety-Certified Software for Mobility and Autonomous Applications
AGCO, Your Agriculture Company, (NYSE:AGCO), a worldwide manufacturer and distributor of agricultural machinery and precision ag technology, announced that it has made a 2.53% equity investment in
![Tufin Introduces Security Policy Builder (SPB) App to Marketplace](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Tufin Introduces Security Policy Builder (SPB) App to Marketplace
Tufin® (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT operations, today announced the release of the Tufin Security Policy Builder (SPB) App, the latest addition to
![Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdEVCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--1b3c47f309e54c35ff476143bba270ac36f5bc61/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Symantec.jpg?locale=us)
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
![CI Global Asset Management Announces December 2021 Distributions for CI ETFs: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBem1LVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3d8fb424903fcea7ece1d64c4b0c3bb9003ef63e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/CI-F_-_RGB_E.jpg?locale=us)
CI Global Asset Management Announces December 2021 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending December 31, 2021 in respect of CI ETFs. In all cases, the distribution will
![Annaly Capital Management, Inc. Promotes Ilker Ertas to Chief Investment Officer: https://mms.businesswire.com/media/20191107006051/en/722862/5/Annaly_Blue.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN1FpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b19d43ddf63abe94ed98ff8737b86c51234a4bb5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Annaly_Blue.jpg?locale=us)
Annaly Capital Management, Inc. Promotes Ilker Ertas to Chief Investment Officer
Annaly Capital Management, Inc. (NYSE: NLY) (“Annaly” or the “Company”) announced today that it has promoted Ilker Ertas to Chief Investment Officer effective immediately. He will continue to
![Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Deathhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death
Pfizer Inc. (NYSE: PFE) today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients)
![Essent Group Ltd. Announces Amended and Extended $825 Million Credit Facility: https://mms.businesswire.com/media/20191108005055/en/520510/5/2016_Essent_Group_R_CMYK.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeG9rRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--34dab77e1f50231bf81b7fff97ec88a4eeac3d4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/2016_Essent_Group_R_CMYK.jpg?locale=us)
Essent Group Ltd. Announces Amended and Extended $825 Million Credit Facility
Essent Group Ltd. (NYSE: ESNT) today announced that it has amended its credit facility (the “Credit Facility”) to increase the total facility from $625 million to $825 million with terms that
![AdvanSix Appoints Farha Aslam to Board of Directors: https://mms.businesswire.com/media/20210330005438/en/868158/5/AdvanSix_Logo_Color_RGB.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXRLVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b5b08b00177a6ea96f7f3179af158059ad9af5a3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AdvanSix_Logo_Color_RGB.jpg?locale=us)
AdvanSix Appoints Farha Aslam to Board of Directors
AdvanSix (NYSE: ASIX) announced today the appointment of Farha Aslam as a new independent member of its Board of Directors. Ms. Aslam is currently Managing Partner of Crescent House Capital, an
Fluor-Backed NuScale Power Signs Agreement to Accelerate Small Modular Reactor Commercialization
Fluor Corporation (NYSE: FLR) announced today that NuScale Power, LLC, in which Fluor is the majority investor, has signed a merger agreement with Spring Valley Acquisition Corp. (NASDAQ: SV)
![Columbia Care Launches the UK’s Broadest Portfolio of Doseable Medical Cannabis Extract Vaporizer Pens; First Company to Manufacture Extract Vaporization Products in the UK: https://mms.businesswire.com/media/20200203005819/en/720533/5/CC_CORPORATE_-01.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2hVSVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9aaf56e524d07c92645b5246a555901838c3aad7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/CC_CORPORATE_-01.jpg?locale=us)
Columbia Care Launches the UK’s Broadest Portfolio of Doseable Medical Cannabis Extract Vaporizer Pens; First Company to Manufacture Extract Vaporization Products in the UK
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer
![DGAP-News: RIB Software SE: Squeeze-out of minority shareholders registered with the commercial register](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
DGAP-News: RIB Software SE: Squeeze-out of minority shareholders registered with the commercial register
![Gold Standard Diagnostics, a Eurofins Technologies Company, Launches CE Marked Assay for the Detection of the Omicron SARS-CoV-2 Variant: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzNhTUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--39aa1a81526ac2a70cd04ea71d1ab318c23b607c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/EUROFINS_.jpg?locale=us)
Gold Standard Diagnostics, a Eurofins Technologies Company, Launches CE Marked Assay for the Detection of the Omicron SARS-CoV-2 Variant
Gold Standard Diagnostics continues its response to the threat of the emerging Omicron SARS-CoV-2 variant by providing innovative diagnostic solutions.
The Omicron SARS-CoV-2 variant has raised
![ADVA wins major German innovation award with its quantum-safe encryption technology](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
ADVA wins major German innovation award with its quantum-safe encryption technology
ADVA (FSE: ADV) today announced that it has won one of Germany’s most renowned innovation prizes for its quantum-safe encryption technology. The accolade recognizes the value of ADVA’s highly
DGAP-News: Deutsche Wohnen SE: Deutsche Wohnen applies for change of segment to General Standard on the regulated market of the Frankfurt Stock Exchange
![DGAP-News: Elmos Semiconductor SE: Sale of wafer fab in Dortmund to the MEMS foundry Silex Microsystems AB - Long-term supply agreement until at least 2027 signed](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DGAP-News: Elmos Semiconductor SE: Sale of wafer fab in Dortmund to the MEMS foundry Silex Microsystems AB - Long-term supply agreement until at least 2027 signed
AIXTRON says YESvGaN / Epitaxy specialist AIXTRON is partner of EU research project YESvGaN / High energy efficiency and low CO2 emissions by using GaN power transistors
DGAP-News: Vossloh Aktiengesellschaft: Vossloh wins another major order from China for rail fastening systems
EQS-News: Global insured catastrophe losses rise to USD 112 billion in 2021, the fourth highest on record, Swiss Re Institute estimates
![EQS-News: Holcim completes bolt-on acquisition in the US: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23785/LafargeHolcim_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBcU1CIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--dc4831c6b62be27b37a420e673523fbc6807fc40/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LafargeHolcim_logo.png?locale=us)
EQS-News: Holcim completes bolt-on acquisition in the US
![2CRSi SA awarded new contract by EdgeMode. EdgeMode significantly increases mining and HPC capacity through additional green high-performance servers. : https://mms.businesswire.com/media/20200604005664/en/796080/5/logo-2crsi.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekNlT1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6d2d3414f021c205113a2b5deddaab1a59a8aa51/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-2crsi.jpg?locale=us)
2CRSi SA awarded new contract by EdgeMode. EdgeMode significantly increases mining and HPC capacity through additional green high-performance servers.
![Poxel Announces its Participation at Upcoming Investor and Scientific Conferences in January 2022: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOTA1Vnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a443757a54f31cbfc57d9b7b8b30d0d59fbe9bd4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/POXEL_LOGO_Q.jpg?locale=us)
Poxel Announces its Participation at Upcoming Investor and Scientific Conferences in January 2022
POXEL SA (Euronext – POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
![CSL Limited announces tender offer to acquire Vifor Pharma Ltd: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMndsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--37beee983e668f5de331d0d69e2c6f07f1240d69/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/VP_logo_rgb.jpg?locale=us)
CSL Limited announces tender offer to acquire Vifor Pharma Ltd
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Global biotechnology leader CSL Limited (ASX: CSL; USOTC:CSLLY) and Vifor Pharma Ltd (SIX:VIFN; ISIN:CH0364749348), a global